U.K.’s NICE Maintains Recommendation for Bioventus’ EXOGEN

The U.K.'s National Institute for Health and Clinical Excellence (NICE) released guidance in support of Bioventus' EXOGEN® ultrasound bone healing device as an alternative to surgery for the treatment of nonunion fractures. NICE originally made its recommendation for EXOGEN in 2013.

External assessment found that while the cost of revision...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us